Valeritas Featured on Fox Business Network’s Top Morning Show

Fox Business Network's show "Mornings with Maria" featured firm client Valeritas Holdings, Inc. In the segment, Valeritas CEO John Timberlake discussed the V-Go daily insulin delivery device, which is the only such device worn as a patch, and is meant to make life easier for those with Type 2 diabetes. John Timberlake was joined by Joe …

Continue reading Valeritas Featured on Fox Business Network’s Top Morning Show

Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

The most recent Wall Street Transcript Medical Devices Report includes an interview with Valeritas, Inc.'s CEO, John Timberlake.  Timberlake discusses in detail Valeritas's V-Go Disposable Insulin Delivery Device. The V-Go is a wearable basal-bolus insulin delivery device that allows patients to deliver insulin at a continuous preset basal rate, with bolus delivery as needed.  The V-Go …

Continue reading Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

Valeritas Financing Round Tops VC Deals for Second Half of 2011

In September 2011, MBBP client Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced it had completed a significant Series C round of financing of $150 million. According to a recent listing by Fierce Medical Devices this Series C Financing was the top venture capital deal in …

Continue reading Valeritas Financing Round Tops VC Deals for Second Half of 2011

MBBP Client Valeritas Receives FDA 510(k) Clearance for Insulin Delivery Device

MBBP client Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, has gained clearance from the U.S. Food and Drug Administration on the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing …

Continue reading MBBP Client Valeritas Receives FDA 510(k) Clearance for Insulin Delivery Device

Valeritas Receives Tax Incentive for Job Creation

Established in 2008, the Massachusetts Life Sciences Initiative allows up to $25 million in tax incentives each year for companies doing research and development, commercialization and manufacturing in the Commonwealth. For 2011, the Mass Life Sciences Center approved $23.9 million in incentives to 30 companies to create almost 1,000 new jobs. As a result of …

Continue reading Valeritas Receives Tax Incentive for Job Creation